Bak BH3 Peptide for cancer targeting research

Bak BH3

US$220.05

Excluding tax and shipping fees

In stock

Description

About Bak BH3

Bak BH3 (Uniprot: Q16611) is a pro-apoptotic peptide derived from BCL-2 family proteins for cancer-targeting research. The Bak BH3 peptide, H-GQVGRQLAIIGDDINR-OH from JPT is produced under strict quality control and quality management.

Bak BH3 - Specifications

Peptide sequence: H-GQVGRQLAIIGDDINR-OH

Amount: 0.5 mg

Purity: > 90% (HPLC/MS)

Counterion: TFA

Delivery Format: Freeze-dried in plastic vial

Application(s): Cancer research

Condition(s)/Topic(s): Cancer

Standard Delivery Time: approx. 3 weeks

Non-RGD Cancer Peptides from JPT

Cancer peptides are widely used to develop targeted diagnostic and therapeutic approaches. They offer different functionalities such as binding tumor-associated receptors, interacting with cellular membranes, or interfering with tumor microenvironment. Depending on the application, these mechanisms enable specific delivery, tumor imaging, and tumor cell killing with low side effects.JPT offers a wide portfolio of high-quality cancer peptides engineered for robust and reproducible research in oncology including RGD and non-RGD cancer peptides.

Benefits of JPT’s Non-RGD Cancer Peptides

Each peptide quality controlled and guaranteed for identity and purity

CoA and HPLC-MS data available

High batch-to-batch consistency

Synthesis protocols designed to avoid toxic contaminants and side products

Provision of freeze dried aliquots for enhanced stability

Proven track record for applications in clinical studies

References

References for Bak BH3

ReferencesRead References with Peptides made by JPT

Documentation

Documentation for Bak BH3

Bak BH3.pdf

Properties

Properties of Bak BH3

0.5 mg

Cancer biomarker research

Cancer peptides

Freeze-dried in plastic vial

Human

BAK (Bcl-2 homologous antagonist/killer)

>90% (HPLC-MS)

No

Further Information to Bak BH3

Values

H-GQVGRQLAIIGDDINR-OH

16mer cancer peptide